DAUNOMYCIN Side Effects

6183667-X | Alopecia, Bone Marrow Failure, Candidiasis, Clostridial Infection, Diarrhoea, Hepatic Failure, Hypophagia, Liver Function Test Abnormal
on Apr 27, 2009 Female patient from JAPAN , child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, bone marrow failure, candidiasis, clostridial infection, diarrhoea, hepatic failure, hypophagia, liver function test abnormal. Daunomycin dosage: 100 Mg/m2, Unk. During the same period patient was treated with PREDNISOLONE AND PREDNISOLONE STEAGLATE (60 Mg/m2, Unk) (View Prednisolone And Prednisolone Steaglate Review and Prednisolone And Prednisolone Steaglate Label ), VINCRISTINE SULFATE (7.5 Mg/m2, Unk) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CYCLOPHOSPHAMIDE (2400 Mg/m2, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (1050 Mg/m2, Unk) (View Cytarabine Review and Cytarabine Label ).

5269989-5 | Ascites, Cerebrovascular Accident, Fluid Imbalance, Pleural Effusion, Respiratory Disorder
Patient was taking Daunomycin (View Usage). Patient had the following side effects: ascites, cerebrovascular accident, fluid imbalance, pleural effusion, respiratory disorder on Mar 13, 2007 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with blast crisis in myelogenous leukaemia and. Daunomycin dosage: 40 Mg/d. During the same period patient was treated with GLEEVEC (800 Mg/d) (View Gleevec Review and Gleevec Label ), CYLOCIDE (120 Mg/d) (View Cylocide Review and Cylocide Label ). Patient was hospitalized.

5140323-4 | Ascites, Cerebrovascular Accident, Fluid Imbalance, Pleural Effusion, Respiratory Disorder
Adverse event was reported on Sep 28, 2006 by a Male patient taking Daunomycin (View Usage) (Dosage: 40 Mg/d) was diagnosed with blast crisis in myelogenous leukaemia and. Location: JAPAN , 77 years of age, After Daunomycin was administered, patient had the following side effects: ascites, cerebrovascular accident, fluid imbalance, pleural effusion, respiratory disorder. During the same period patient was treated with GLEEVEC (800 Mg/d) (View Gleevec Review and Gleevec Label ), CYLOCIDE (120 Mg/d) (View Cylocide Review and Cylocide Label ). Patient was hospitalized.

4867798-X | Cerebral Haemorrhage, Headache, Nervous System Disorder, Venous Thrombosis
on Dec 23, 2005 Female patient from UNITED STATES , weighting 134.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, headache (What is headache?), nervous system disorder, venous thrombosis. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), ELSPAR (See Image) (View Elspar Review and Elspar Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DECADRON (View Decadron Review and Decadron Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.


4823005-5 | Abdominal Pain, Constipation, Febrile Neutropenia, Herpes Simplex, Loss Of Consciousness, Lung Consolidation, Mouth Ulceration, Perivascular Dermatitis
on Nov 08, 2005 Male patient from UNITED STATES , weighting 131.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), febrile neutropenia, herpes simplex (What is herpes simplex?), loss of consciousness, lung consolidation, mouth ulceration, perivascular dermatitis. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), ELSPAR (See Image) (View Elspar Review and Elspar Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TEQUIN (View Tequin Review and Tequin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), CEFEPRIME (View Cefeprime Review and Cefeprime Label ). Patient was hospitalized.

4822548-8 | Abdominal Pain, Aspergillosis, Bronchial Obstruction, Constipation, Febrile Neutropenia, Herpes Simplex, Lung Consolidation, Lymphocytic Infiltration, Mouth Ulceration
Patient was taking Daunomycin (View Usage). After Daunomycin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), aspergillosis, bronchial obstruction, constipation (What is constipation?), febrile neutropenia, herpes simplex (What is herpes simplex?), lung consolidation, lymphocytic infiltration, mouth ulceration on Nov 04, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 131.4 lb, was diagnosed with acute lymphocytic leukaemia and. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (See Image) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TEQUIN (View Tequin Review and Tequin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), CEFEPIME (View Cefepime Review and Cefepime Label ). Patient was hospitalized.

4818919-6 | Bacterial Infection, Blood Culture Positive, Cholecystitis, Enterococcal Infection, Hyperpyrexia, Klebsiella Infection, Ovarian Disorder, Platelet Count Decreased
Adverse event was reported on Nov 02, 2005 by a Female patient taking Daunomycin (View Usage) (Dosage: See Image) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 151.9 lb, Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), blood culture positive, cholecystitis, enterococcal infection, hyperpyrexia, klebsiella infection, ovarian disorder, platelet count decreased. During the same period patient was treated with CYTARABINE (See Image) (View Cytarabine Review and Cytarabine Label ), GEMTUZUMAB OZOGAMICIN (See Image) (View Gemtuzumab Ozogamicin Review and Gemtuzumab Ozogamicin Label ). Patient was hospitalized.

4816635-8 | Pneumonia, Pyrexia
on Oct 31, 2005 Male patient from UNITED STATES , weighting 131.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), pyrexia. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (See Image) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4810925-0 | Colitis, Pneumothorax
on Oct 25, 2005 Male patient from UNITED STATES , weighting 181.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). After Daunomycin was administered, patient had the following side effects: colitis, pneumothorax. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (See Image) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4784467-5 | Acute Respiratory Distress Syndrome, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Asterixis, Blood Bilirubin Increased, Blood Creatinine Increased, Bone Marrow Disorder, Confusional State
Patient was taking Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asterixis, blood bilirubin increased, blood creatinine increased, bone marrow disorder, confusional state on Sep 29, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with acute myeloid leukaemia and. Daunomycin dosage: See Image. During the same period patient was treated with CYTARABINE (See Image) (View Cytarabine Review and Cytarabine Label ), MYLOTARG (See Image) (View Mylotarg Review and Mylotarg Label ), GROWTH FACTOR (See Image) (View Growth Factor Review and Growth Factor Label ). Patient was hospitalized.

4783442-4 | No Adverse Effect
Adverse event was reported on Sep 28, 2005 by a Female patient taking Daunomycin (View Usage) (Dosage: See Image) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , weighting 169.8 lb, Patient had the following side effects: no adverse effect. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (See Image) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4781158-1 | Hyperglycaemia
on Sep 27, 2005 Female patient from UNITED STATES , weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). After Daunomycin was administered, patient had the following side effects: hyperglycaemia. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (See Image) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4771607-7 | Febrile Neutropenia, Fungal Rash, Jaundice, Laboratory Test Abnormal, Mental Status Changes, Pharyngolaryngeal Pain, Respiratory Disorder, Systemic Mycosis
on Sep 13, 2005 Male patient from UNITED STATES , weighting 149.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, fungal rash, jaundice (What is jaundice?), laboratory test abnormal, mental status changes, pharyngolaryngeal pain, respiratory disorder, systemic mycosis. Daunomycin dosage: See Image. During the same period patient was treated with CYTARABINE (See Image) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

4758770-9 | Blood Culture Positive, Febrile Neutropenia
Patient was taking Daunomycin (View Usage). Patient had the following side effects: blood culture positive, febrile neutropenia on Aug 31, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 163.1 lb, was diagnosed with acute lymphocytic leukaemia and. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (See Image) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4738588-3 | Hypoxia, Lung Infiltration, Pneumonitis
Adverse event was reported on Aug 08, 2005 by a Male patient taking Daunomycin (View Usage) (Dosage: See Image) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 187.4 lb, After Daunomycin was administered, patient had the following side effects: hypoxia, lung infiltration, pneumonitis. During the same period patient was treated with CYTARABINE (See Image) (View Cytarabine Review and Cytarabine Label ), CYCLOSPORINE (See Image) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

4736242-5 | Cerebral Ischaemia, Fungal Infection, Hypoaesthesia, Ischaemic Stroke, Laboratory Test Abnormal, Meningioma, Pancreatitis, Paraesthesia, Sensory Loss
on Aug 04, 2005 Female patient from UNITED STATES , weighting 177.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral ischaemia, fungal infection (What is fungal infection?), hypoaesthesia, ischaemic stroke, laboratory test abnormal, meningioma, pancreatitis, paraesthesia, sensory loss. Daunomycin dosage: See Image. During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), ELSPAR (See Image) (View Elspar Review and Elspar Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4735779-2 | Chest Discomfort, Dyspnoea, Electrocardiogram St Segment Elevation, Pericarditis, Respiratory Distress, Respiratory Failure
on Aug 03, 2005 Male patient from UNITED STATES , weighting 218.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunomycin (View Usage). Patient had the following side effects: chest discomfort, dyspnoea, electrocardiogram st segment elevation, pericarditis, respiratory distress, respiratory failure. Daunomycin dosage: See Image. During the same period patient was treated with ARA C (See Image) (View Ara-c Review and Ara-c Label ), GEMTUZUMAB (See Image) (View Gemtuzumab Review and Gemtuzumab Label ). Patient was hospitalized.

4731477-X | Pyrexia
Patient was taking Daunomycin (View Usage). After Daunomycin was administered, patient had the following side effects: pyrexia on Aug 01, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 110.7 lb, was diagnosed with acute myeloid leukaemia and. Daunomycin dosage: See Image. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN (See Image) (View Gemtuzumab Ozogamicin Review and Gemtuzumab Ozogamicin Label ). Patient was hospitalized.

4724655-7 | Atelectasis, Bacterial Infection, Blood Bilirubin Increased, Pleural Effusion, Sepsis, Streptococcal Infection
Adverse event was reported on Jul 19, 2005 by a Male patient taking Daunomycin (View Usage) (Dosage: See Image) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , weighting 174.6 lb, Patient experienced the following unwanted or unexpected effects: atelectasis, bacterial infection (What is bacterial infection?), blood bilirubin increased, pleural effusion, sepsis (What is sepsis?), streptococcal infection (What is streptococcal infection?). During the same period patient was treated with VINCRISTINE SULFATE (See Image) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ), L ASPAPAGINASE (See Image) (View L-aspapaginase Review and L-aspapaginase Label ), METHOTREXATE (See Image) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4708267-7 | Dialysis, Tumour Lysis Syndrome
on Jul 05, 2005 Male patient from UNITED STATES , weighting 178.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). Patient had the following side effects: dialysis (What is dialysis?), tumour lysis syndrome. Daunomycin dosage: 60mg/m2 Ivp On Days 1, 8, 15, And 22. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1,8, 15, And 22) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (60 Mg/m2 Po Qd For 28 Days) (View Prednisone Review and Prednisone Label ), ELSPAR (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View Elspar Review and Elspar Label ), METHOTREXATE (12.5 Mg It On Day 15) (View Methotrexate Review and Methotrexate Label ).

4707374-2 | Anxiety, Depression
on Jul 01, 2005 Male patient from UNITED STATES , weighting 156.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). After Daunomycin was administered, patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?). Daunomycin dosage: 60 Mg/m2 Ivp On Days 1,8,15, And 22. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1,8,15,and 22. Note: Maximum Dose 2mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE TAB (60 Mg/m2 Po Qd For 28 Days) (View Prednisone Tab Review and Prednisone Tab Label ), ELSPAR (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View Elspar Review and Elspar Label ), METHOTREXATE (12.5 Mg It On Day 15 Only Unless Pt. Received Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4697893-X | Activated Partial Thromboplastin Time Prolonged, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Fibrinogen Decreased, Chest Pain, Coagulopathy, Dizziness
Patient was taking Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood fibrinogen decreased, chest pain (What is chest pain?), coagulopathy, dizziness (What is dizziness?) on Jun 21, 2005 from Additional patient health information: Male patient , weighting 151.2 lb, was diagnosed with acute lymphocytic leukaemia and. Daunomycin dosage: 60 Mg/m2 Ivp On Days 1, 8, 15, And 22. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1, 8, 15, And 22) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE TAB (60 Mg/m2 Po Qd For 28 Days) (View Prednisone Tab Review and Prednisone Tab Label ), L ASPARAGINASE (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (12.5 Mg It On Dasy 15 Only Unless Pt. Received Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ).

4664353-1 | Atelectasis, Bacterial Sepsis, Blood Bilirubin Increased, Pleural Effusion
Adverse event was reported on May 16, 2005 by a Male patient taking Daunomycin (View Usage) (Dosage: 60mg/m2 Ivp On Days 1,8,15,and 22) . Location: , weighting 174.6 lb, Patient had the following side effects: atelectasis, bacterial sepsis, blood bilirubin increased, pleural effusion. During the same period patient was treated with VINCRISTINE SULFATE (1.4mg/m2 Ivp On Days 1,8,15, And 22. Note Maximum Dose 2mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (60mg/m2 Po Qd For 28 Days) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (12.5mg It On Day 15 Only Unless Pt Received Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4652123-X | Acute Respiratory Distress Syndrome, Agitation, Ammonia Increased, Apnoea, Haemodialysis, Hypermetabolism, Hypoxia, Mental Status Changes, Pyrexia
on May 02, 2005 Male patient from , weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). After Daunomycin was administered, patient had the following side effects: acute respiratory distress syndrome, agitation, ammonia increased, apnoea, haemodialysis, hypermetabolism, hypoxia, mental status changes, pyrexia. Daunomycin dosage: 60 Mg/m2 Ivp On Days 1, 8, 15, And 22. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1, 8, 15, And 22 . Note Maximum Dose 2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE TAB (60 Mg/m2 Po Qd For 28 Days) (View Prednisone Tab Review and Prednisone Tab Label ), L ASPARAGINASE (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (12.5 Mg It On Days 15 Only Unless Pt. Received Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ).

4647762-6 | Atelectasis, Bacterial Infection, Blood Bilirubin Increased, Blood Culture Positive, Pleural Effusion, Streptococcal Sepsis
on Apr 27, 2005 Male patient from , weighting 174.6 lb, was treated with Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, bacterial infection (What is bacterial infection?), blood bilirubin increased, blood culture positive, pleural effusion, streptococcal sepsis. Daunomycin dosage: 60mg/m2 Ivp On Days 1,8,15,and 22. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1,8,15, And 22. Note: Maximum Dose 2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (60 Mg/m2 Po Qd For 28 Days) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (12.5 Mg It On Day 15 Only Unless Pt. Received Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4647207-6 | Atelectasis, Blood Bilirubin Increased, Pleural Effusion, Streptococcal Sepsis
Patient was taking Daunomycin (View Usage). Patient had the following side effects: atelectasis, blood bilirubin increased, pleural effusion, streptococcal sepsis on Apr 26, 2005 from Additional patient health information: Male patient , weighting 174.6 lb, was diagnosed with acute lymphocytic leukaemia and. Daunomycin dosage: 60 Mg/m2 Ivp On Days 1, 8,15 And 22.. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1, 8,15 And 22. Note: Maximum Dose 2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (60 Mg/m2 Po Qd For 28 Days) (View Prednisone Review and Prednisone Label ), L ASPARAGINASE (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View L-asparaginase Review and L-asparaginase Label ), METHOTREXATE (12.5 Mg It On Day 15 Only Unless Pt. Received Treatment For Cns Leukemia.) (View Methotrexate Review and Methotrexate Label ).

4642291-8 | Atelectasis, Blood Bilirubin Increased, Blood Culture Positive, Pleural Effusion, Streptococcal Infection
Adverse event was reported on Apr 21, 2005 by a Male patient taking Daunomycin (View Usage) (Dosage: 60 Mg/m2 Ivp On Days 1, 8, 15 And 22) was diagnosed with acute lymphocytic leukaemia and. Location: , weighting 174.6 lb, After Daunomycin was administered, patient had the following side effects: atelectasis, blood bilirubin increased, blood culture positive, pleural effusion, streptococcal infection (What is streptococcal infection?). During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1, 8, 15, And 22 Note: Maximum Dose 2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE TAB (60 Mg/m2 Po Qd For 28 Days.) (View Prednisone Tab Review and Prednisone Tab Label ), ELSPAR (1000 Unit/m2 Iv Over 30 Min Qd On Days 17-28.) (View Elspar Review and Elspar Label ), METHOTREXATE (12.5 Mg It On Day 15 Only Unless Pt. Received Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ).

4633176-1 | Acute Respiratory Distress Syndrome, Agitation, Apnoea, Hypermetabolism, Hypoxia, Lung Infiltration, Mental Status Changes, Metabolic Disorder, Pyrexia
on Apr 11, 2005 Male patient from , weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, agitation, apnoea, hypermetabolism, hypoxia, lung infiltration, mental status changes, metabolic disorder (What is metabolic disorder?), pyrexia. Daunomycin dosage: 60 Mg/m2 Ivp On Days 1, 8, 15, And 22. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1, 8, 15 And 22 Note: Maximum Dose 2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (60 Mg/m2 Po Qd For 28 Days.) (View Prednisone Review and Prednisone Label ), ELSPAR (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View Elspar Review and Elspar Label ), METHOTREXATE (12.5 Mg It On Days 15 Only Unless Pt. Receive Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ).

4626828-0 | Dialysis, Tumour Lysis Syndrome
on Apr 01, 2005 Male patient from , weighting 178.1 lb, was treated with Daunomycin (View Usage). Patient had the following side effects: dialysis (What is dialysis?), tumour lysis syndrome. Daunomycin dosage: 60 Mg/m2 Ivp On Days 1,8,15 And 22. During the same period patient was treated with VINCRISTINE SULFATE (1.4 Mg/m2 Ivp On Days 1,8,15 And 22 (note: Maximum Dose 2 Mg)) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISONE (60 Mg/m2 Po Qd For 28 Days) (View Prednisone Review and Prednisone Label ), ELSPAR (10000 Unit/m2 Iv Over 30 Min Qd On Days 17-28) (View Elspar Review and Elspar Label ), METHOTREXATE (12.5 Mg It On Day 15 Only Unless Pt Received Treatment For Cns Leukemia) (View Methotrexate Review and Methotrexate Label ).

4622406-8 | Cerebral Haemorrhage, Disseminated Intravascular Coagulation, Enterobacter Infection, Hypotension, Pulmonary Oedema, Sepsis, Serratia Infection, Streptococcal Infection
Patient was taking Daunomycin (View Usage). After Daunomycin was administered, patient had the following side effects: cerebral haemorrhage, disseminated intravascular coagulation, enterobacter infection, hypotension, pulmonary oedema, sepsis (What is sepsis?), serratia infection, streptococcal infection (What is streptococcal infection?) on Mar 25, 2005 from Additional patient health information: Female patient , 16 years of age, weighting 94.80 lb, was diagnosed with acute lymphocytic leukaemia and. Daunomycin dosage: 25 Mg Per M2 (40 Mg) Weekly. During the same period patient was treated with PREDNISONE (95 Mg Per Day) (View Prednisone Review and Prednisone Label ), INSULIN (View Insulin Review and Insulin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ZOSYN (View Zosyn Review and Zosyn Label ), DOPAMINE (View Dopamine Review and Dopamine Label ), DOBUTAMIN (View Dobutamin Review and Dobutamin Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).

4579438-8 | Blood Culture Positive, Escherichia Infection, Neutropenia
Adverse event was reported on Feb 10, 2005 by a Female patient taking Daunomycin (View Usage) (Dosage: 89.5 Mg Over 24 Hours On Days 1-3) . Location: , weighting 202.8 lb, Patient experienced the following unwanted or unexpected effects: blood culture positive, escherichia infection, neutropenia. During the same period patient was treated with CYTARABINE (398 Mg Iv Over 24 Hours Days 1-7) (View Cytarabine Review and Cytarabine Label ).